Insider filing · MAZE
Amy Bachrodt
SVP, Finance
profile →
Maze Therapeutics, Inc.
MAZE · Healthcare · 41 filings in 24 months
ticker →
Amy Bachrodt sold $581K of Maze Therapeutics (MAZE)
Executed Dec 29 2025, disclosed Dec 31 2025, 2 days later.
Value, as filed
$581K
14,400 sh across 2 lots
Executed
Dec 29 2025
the trade date, as filed
Disclosed
Dec 31 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ABAmy Bachrodt (SVP, Finance) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $581K of MAZE (14,400 sh across 2 lots, as filed), executed Dec 29 2025.
The name
MAZEHealthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Amy Bachrodt in MAZE
MAZESALE
Maze Therapeutics, Inc.
$168K3,700 sh × $45.47
Exec Mar 2
Filed Mar 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $187K
4,064 sh × $46.03
Exec Feb 2
Filed Feb 4 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $228K
5,000 sh × $45.52
Exec Jan 22
Filed Jan 26 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $103K
2,595 sh × $39.57
Exec Jan 2
Filed Jan 6 · 5:30 PM ET